ARCHIVES

Lasagna Committee Report Advocates Faster Drug approval, Insurance Coverage For Investigational Drugs, Ancillary Costs

This article is from The Cancer Letter archive.

Vol. 16 No. 34 | September 7, 1990

Download PDF Visit The Full Archive

Related Articles

Executive Committee, Board of Scientific Advisors concur.

January 2, 2004

Race, Age Play Role In Delay Of Surgery For Breast Cancer

December 28, 2007

Broder’s Conundrum: How To Let Congress Know NCI Needs More Money Without Asking For it

March 17, 1989

Ellence Has Lower Risk Of Heart Damage, Study Finds

August 27, 2004

Zaltrap Price Cut In Half Effective Immediately

November 8, 2012

Organ Site Review Committee Recommends Continuing Program Despite Some Weak Areas, Suggests Changes

February 5, 1982